Contact Information: Contact: Ralph Barry Chief Business Officer Aegis Therapeutics LLC 1-858-618-1400 Ext. 102 Email: Email Contact
Aegis Therapeutics to Present Intravail(R) and ProTek(R) Technologies at the "Drug Delivery 2007 Conference" in San Francisco on April 10, 2007
| Source: Aegis Therapeutics LLC
SAN DIEGO, CA -- (MARKET WIRE) -- April 3, 2007 -- Aegis Therapeutics, a leader in intranasal
drug delivery, will present a talk entitled: "High-Efficiency Delivery of
Peptides, Proteins, and Other Macromolecules via Intranasal & Other
Transmucosal Routes" at the Arrowhead "Drug Delivery 2007 Conference". The
conference will be held on April 10, 2007 at the Crown Plaza Union Square,
San Francisco. Dr. Edward T. Maggio, President and CEO of Aegis, will
describe the application of Aegis' Intravail® non-invasive drug delivery
technology, and Aegis' ProTek® protein stabilization technology to
specific peptide and protein therapeutics.
Information about the conference may be obtained from the following
website:
https://www.arrowheadpublishers.com/conferences/drugdelivery2007/.
About Aegis Therapeutics
Aegis Therapeutics LLC is a drug delivery technology company
commercializing its patented or proprietary drug delivery and drug
formulation technologies through product-specific licenses. Our
Intravail® drug delivery technology enables the non-invasive delivery of
a broad range of protein, peptide and non-peptide macromolecular
therapeutics that can currently only be administered by injection. Aegis'
Intravail® absorption enhancement agents provide exceptionally high and
unmatched bioavailability performance, comparable in efficiency to
subcutaneous injection, via the intranasal and other mucosal membrane
administration routes. Our ProTek® technology allows creation of
proprietary, easily manufacturable, and stable aqueous or lyophilized
dosage forms that maintain the integrity and physiological activity of many
protein and peptide therapeutics. ProTek® technology is applicable to
injectable, intranasal, and other dosage forms of peptide or protein
therapeutics.
For more information about Aegis, please visit the Aegis website at:
http://www.aegisthera.com.